3 glp 1 drugs More people with type diabetes are using GLP-1 drugs, study finds, despite limited evidence on safety or effectiveness GLP-1 drugs may have a

Gut Microbes 16 , 2329147 (2024)

Patel BG, Rudnicki M, Yu J, Shu Y, Taylor RN

Yes, oral BPC-157 is commonly associated with gastrointestinal support

Durability of Results: Maintenance Studies: Tirzepatide (SURMOUNT-3): Continued treatment: Additional 5.5% weight loss Stopped treatment: Regained 14% of weight Conclusion: Need ongoing treatment Semaglutide (STEP-4): Continued treatment: Maintained loss, continued losing Stopped treatment: Regained most weight Conclusion: Need ongoing treatment Phentermine: FDA-approved for 12 weeks only Weight regain after stopping is universal Not a long-term solution All Weight Loss Medications: Obesity is chronic disease Medications treat symptoms, dont cure Stopping medication weight regain Long-term or indefinite use necessary for sustained results Safety Profile Comparison: Discontinuation Due to Side Effects: Tirzepatide: 6.2% Semaglutide: 6.9% Liraglutide: 9.9% Naltrexone-bupropion: 25% (very high) Orlistat: 15-20% Phentermine-topiramate: 8-10% GLP-1s have excellent tolerability considering their effectiveness

Keep your Vitamin C routines simple

Heres how long different results typically last